Associate Professor Maija Kohonen-Corish Related News
Improved rationale for attacking colorectal cancer
MEDIA RELEASE:
17 Jan 2011
Some people respond very well to chemotherapy or radiotherapy for colorectal cancer, while others hardly respond at all – a fact that has been a bit of a mystery until now. A team of Garvan scientists believes the outcome may depend on a gene called ‘MCC’ – which happens to be expressed at low levels in a subset of colorectal cancers. Their findings give them a rationale for checking patients' responses to therapy.
